Greenland Mines Ltd. Common Stock (NASDAQ:GRML) Trading Up 7.9% – Here’s Why

Greenland Mines Ltd. Common Stock (NASDAQ:GRML)’s share price was up 7.9% on Friday . The company traded as high as $0.49 and last traded at $0.4847. Approximately 3,261,775 shares were traded during trading, a decline of 5% from the average daily volume of 3,447,769 shares. The stock had previously closed at $0.4494.

Analyst Ratings Changes

A number of equities analysts have recently commented on GRML shares. Weiss Ratings reissued a “sell (e+)” rating on shares of Greenland Mines Ltd. Common Stock in a report on Wednesday. Wall Street Zen lowered shares of Greenland Mines Ltd. Common Stock from a “hold” rating to a “sell” rating in a report on Monday, March 16th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock currently has a consensus rating of “Sell”.

Greenland Mines Ltd. Common Stock Trading Up 7.9%

The stock’s fifty day moving average price is $0.48 and its 200 day moving average price is $0.44. The stock has a market cap of $58.77 million, a P/E ratio of -1.51 and a beta of 8.79.

Hedge Funds Weigh In On Greenland Mines Ltd. Common Stock

Institutional investors have recently made changes to their positions in the stock. Jane Street Group LLC bought a new position in shares of Greenland Mines Ltd. Common Stock in the 2nd quarter worth $26,000. XTX Topco Ltd boosted its stake in shares of Greenland Mines Ltd. Common Stock by 101.2% in the 4th quarter. XTX Topco Ltd now owns 160,569 shares of the company’s stock valued at $46,000 after purchasing an additional 80,768 shares in the last quarter. Renaissance Technologies LLC purchased a new stake in shares of Greenland Mines Ltd. Common Stock in the 4th quarter valued at $126,000. Geode Capital Management LLC boosted its stake in shares of Greenland Mines Ltd. Common Stock by 51.8% in the 4th quarter. Geode Capital Management LLC now owns 491,832 shares of the company’s stock valued at $142,000 after purchasing an additional 167,905 shares in the last quarter. Finally, Brummer Multi Strategy AB purchased a new stake in shares of Greenland Mines Ltd. Common Stock in the 4th quarter valued at $175,000. Institutional investors own 20.07% of the company’s stock.

About Greenland Mines Ltd. Common Stock

Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases – cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.